New drug approval: Ciltacabtagene autoleucel - in patients with relapsed or refractory multiple myeloma who received 3 or more lines of therapy

被引：0
作者：
Chacon, Aurelia [1 ]
Bobin, Arthur [1 ]
Leleu, Xavier [1 ]
机构：
[1] CHU Poitiers, Serv Oncohematol, 2 Rue Mil,Cs 90577, F-86000 Poitiers, France
来源：
BULLETIN DU CANCER | 2022年 / 109卷 / 10期
关键词：
Multiple myeloma; CAR T; Anti-BCMA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：993 / 995
页数：3
相关论文
共 50 条
  • [31] Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
    Pantani, Lucia
    Zamagni, Elena
    Zannetti, Beatrice Anna
    Pezzi, Annalisa
    Tacchetti, Paola
    Brioli, Annamaria
    Mancuso, Katia
    Perrone, Giulia
    Rocchi, Serena
    Tosi, Patrizia
    Cavo, Michele
    ANNALS OF HEMATOLOGY, 2014, 93 (01) : 123 - 128
  • [32] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
    Hus, Marek
    Grzasko, Norbert
    Szostek, Marta
    Pluta, Andrzej
    Helbig, Grzegorz
    Woszczyk, Dariusz
    Adamczyk-Cioch, Maria
    Jawniak, Dariusz
    Legiec, Wojciech
    Morawska, Marta
    Kozinska, Justyna
    Wacinski, Piotr
    Dmoszynska, Anna
    ANNALS OF HEMATOLOGY, 2011, 90 (10) : 1161 - 1166
  • [33] Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
    Marek Hus
    Norbert Grzasko
    Marta Szostek
    Andrzej Pluta
    Grzegorz Helbig
    Dariusz Woszczyk
    Maria Adamczyk-Cioch
    Dariusz Jawniak
    Wojciech Legiec
    Marta Morawska
    Justyna Kozinska
    Piotr Waciński
    Anna Dmoszynska
    Annals of Hematology, 2011, 90 : 1161 - 1166
  • [34] Infections associated with CAR-T cell therapy in patients with relapsed refractory multiple myeloma: Risks and prevention strategies
    An, Jing
    Zhao, Jie
    Zou, Ping
    Zhang, Yicheng
    Wei, Junni
    Tian, Weiwei
    Wei, Jia
    CANCER MEDICINE, 2024, 13 (12):
  • [35] Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients
    Alegre, Adrian
    Aguado, Beatriz
    Giraldo, Pilar
    Rios, Eduardo
    Canovas, Araceli
    Ibanez, Angela
    Castillo, Inmaculada
    Hernandez, Miguel T.
    Oriol, Albert
    Palomera, Luis
    Rodriguez, Juan-N.
    Garcia, Flor-L.
    Calvo, Jose M.
    Martinez-Chamorro, Carmen
    de la Serna, Javier
    Lahuerta, Juan-J.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 351 - 360
  • [36] Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review
    He, Xuepeng
    Yang, Kai
    Chen, Peng
    Liu, Bing
    Zhang, Yuan
    Wang, Fang
    Guo, Zhi
    Liu, Xiaodong
    Lou, Jinxing
    Chen, Huiren
    ONCOTARGETS AND THERAPY, 2014, 7 : 1593 - 1599
  • [37] Lenalidomide is effective as salvage therapy in refractory or relapsed multiple myeloma: analysis of the Spanish Compassionate Use Registry in advanced patients
    Adrián Alegre
    Beatriz Aguado
    Pilar Giraldo
    Eduardo Ríos
    Araceli Cánovas
    Ángela Ibáñez
    Inmaculada Castillo
    Miguel T. Hernández
    Albert Oriol
    Luis Palomera
    Juan-N. Rodríguez
    Flor-L. García
    José M. Calvo
    Carmen Martínez-Chamorro
    Javier de la Serna
    Juan-J. Lahuerta
    International Journal of Hematology, 2011, 93 : 351 - 360
  • [38] Targeting GPRC5D With Talquetamab: A New Frontier in Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma
    Shaver, Jacob
    Horton, Daniel
    Halford, Zachery
    ANNALS OF PHARMACOTHERAPY, 2025, 59 (04) : 350 - 363
  • [39] Bortezomib and dexamethasone as salvage therapy in patients with relapsed/refractory multiple myeloma: analysis of long-term clinical outcomes
    Lucia Pantani
    Elena Zamagni
    Beatrice Anna Zannetti
    Annalisa Pezzi
    Paola Tacchetti
    Annamaria Brioli
    Katia Mancuso
    Giulia Perrone
    Serena Rocchi
    Patrizia Tosi
    Michele Cavo
    Annals of Hematology, 2014, 93 : 123 - 128
  • [40] Analysis of the Efficacy of Thalidomide Plus Dexamethasone-Based Regimens in Patients With Relapsed/Refractory Multiple Myeloma Who Received Prior Chemotherapy, Including Bortezomib and Lenalidomide: KMM-166 Study
    Jung, Ki Sun
    Kim, Kihyun
    Kim, Hyo Jung
    Kim, Sung Hyun
    Lee, Jeong-Ok
    Kim, Jin Seok
    Lee, Je-Jung
    Eom, Hyeon-Seok
    Min, Chang-Ki
    Shin, Ho-Jin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (02) : E97 - E104
12345